Myelonets define spatiotemporal immunosuppressive programs in ovarian cancer

Niemiec, I., Shabanova, A., Ruuska, E., Tissarinen, M., Liang, Z., Anandagoda, G., Shah, S., Kang, Z., Junquera, A., Salko, M., et al.

10.64898/2026.08.26.26361128 · was preprinted

Surfaced because: matches the platform's topic region.

relevance 0.36 openness 0.00 novelty 0.38

Abstract

High-grade serous ovarian carcinoma (HGSC) responds poorly to immune checkpoint blockade, partly due to a macrophage-dominated immunosuppressive microenvironment. We integrated single-cell spatial proteomics and spatial transcriptomics across 50 HGSC tumors and applied SPACEstat to resolve higher-order immune communities and their transcriptional programs. We identified six immune community types, with macrophage-dominated Myelonets representing the predominant spatial pattern of immune organisation. In chemotherapy-exposed tumors, Myelonets showed coordinated lipid metabolism-immunosuppression and inflammation-MHC-II macrophage transcriptional programs, with SPP1, C1Q, VEGF, MMPs, and CCL18 linked to immunosuppressive states and fibroblasts emerging as key mediators of macrophage communication. Chemotherapy contracted large Myelonets while increasing CD8+ T-cell organization into Lymphonets. Persistent macrophage dominance within Myelonets was associated with adverse outcomes among patients who achieved a complete response to treatment. Together, we identify Myelonets as clinically relevant, multicellular immunoregulatory niches sustained by spatiotemporally coordinated macrophage programs and stromal crosstalk.

Lifecycle

medrxiv v1 2026-08-31 source ↗

Discussion

No qualifying discussion yet.